UnitedHealth Group closed at $371.90, up 1.83% and ahead of the S&P 500's 0.73% gain, as investors look toward the insurer's October 13, 2026 earnings disclosure. Analysts expect earnings per share of $4.12, a 41.1% rise from the same quarter a year earlier, while revenue is projected at $111.38 billion, down 1.57% year over year. For the full year, the Zacks Consensus Estimates forecast earnings of $19.85 per share and revenue of $446.78 billion, changes of +21.41% and -0.18% respectively. The stock carries a Zacks Rank of #2 (Buy) and trades at a forward P/E of 18.4, a discount to the industry average of 21.25, with a PEG ratio of 1.37. The Medical - HMOs industry holds a Zacks Industry Rank of 21, placing it in the top 9% of more than 250 industries.
UnitedHealth Group IncorporatedShares rose ahead of the Oct 13 earnings report, with analysts expecting EPS of $4.12 (+41.1% YoY) but revenue down 1.57%; Zacks Rank #2 and forward P/E discount are valuation context.
